No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
12 Health Care Stocks Moving In Monday's Intraday Session
Nexalin Technology Shares Are Trading Lower After the Company Announced a $5 Million Public Offering.
Press Release: Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock
Nexalin Technology Plans To Submit Q-Submission To FDA Related To Gen-2 SYNC System
Express News | Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 Sync Following Encouraging Data and Preliminary FDA Feedback
Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback
